Lymphoma; Diseases and Conditions; Lung Cancer; Personalized Medicine; Immune System; Wounds and Healing; Stem Cells; Patient Education and Counseling

First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

Early results from a Phase I clinical trial of AT101, a new CAR T cell therapy that uses a distinct…

2 years ago